Sandoz Canada Aims For 10 Biosimilar Launches In Next Decade
Pegfilgrastim And Rituximab Biosimilars Coming Soon
Speaking with Generics Bulletin as Sandoz Canada unveiled its landmark public education campaign, The Biosimilars Generation, Karine Matteau, the company’s biosimilars leader, talked about how it plans to remain a leader in the biosimilars field as well as the company’s response to the COVID-19 pandemic.
